CDDO-Me was obtained from the National Cancer Institute, Bethesda, MD through the Rapid Access to Intervention Development Program. A 100 mM stock solution of CDDO-Me was prepared in DMSO, which was subsequently diluted in tissue culture medium to obtain the working concentrations. Antibodies against PARP-1, NF-κB (p65), Sp1, c-Myc and β-actin were purchased from Santa Cruz Biotechnology, Inc. (Santa Cruz, CA). Anti-hTERT and p-TERT (Ser824) antibodies were obtained from-Abcam Inc. (Cambridge, MA). Antibodies against DNMT1 and DNTM3α were from Cell Signaling (Danvers, MA). Anti-acetylated histone H3 at lysine 9 (ac-H3K9), anti- acetylated histone H4 (ac-H4), anti-histone dimethyl-H3 lysine 4 (di-me-H3K4) and anti-trimethy-H3 lysine 9 (ac-tri-me-H3K9) were purchased from Millipore (Temecula, CA). Annexin V-FITC apoptosis detection kit II was obtained from BD Pharmingen (San Diego, CA, USA) and TRAPeze telomerase detection kit was purchased from Millipore (Millipore, Temecula, CA).
Antibodies against dnmt1 and dntm3α
Manufactured by Cell Signaling Technology
Antibodies against DNMT1 and DNMT3α are laboratory reagents used to detect and analyze the expression of these proteins in biological samples. DNMT1 and DNMT3α are DNA methyltransferase enzymes involved in the regulation of gene expression. These antibodies can be used in various applications, such as Western blotting, immunohistochemistry, and immunofluorescence, to study the role of these proteins in cellular processes.
Automatically generated - may contain errors
Lab products found in correlation
Trapeze telomerase detection kit, by Merck Group (2 mentions)
Antibodies against parp 1, by Santa Cruz Biotechnology (2 mentions)
Anti htert and p tert ser824 antibodies, by Abcam (2 mentions)
Anti trimethy h3 lysine 9 ac tri me h3k9, by Merck Group (2 mentions)
C myc, by Santa Cruz Biotechnology (2 mentions)
Fitc annexin 5 apoptosis detection kit 2, by BD (2 mentions)
β actin, by Santa Cruz Biotechnology (2 mentions)
2 protocols using antibodies against dnmt1 and dntm3α
1
CDDO-Me Induced Epigenetic Modifications
2
CDDO-Me Induced Epigenetic Modifications
Check if the same lab product or an alternative is used in the 5 most similar protocols
+ Expand
CDDO-Me was obtained from the National Cancer Institute, Bethesda, MD through the Rapid Access to Intervention Development Program. A 100 mM stock solution of CDDO-Me was prepared in DMSO, which was subsequently diluted in tissue culture medium to obtain the working concentrations. Antibodies against PARP-1, NF-κB (p65), Sp1, c-Myc and β-actin were purchased from Santa Cruz Biotechnology, Inc. (Santa Cruz, CA). Anti-hTERT and p-TERT (Ser824) antibodies were obtained from-Abcam Inc. (Cambridge, MA). Antibodies against DNMT1 and DNTM3α were from Cell Signaling (Danvers, MA). Anti-acetylated histone H3 at lysine 9 (ac-H3K9), anti- acetylated histone H4 (ac-H4), anti-histone dimethyl-H3 lysine 4 (di-me-H3K4) and anti-trimethy-H3 lysine 9 (ac-tri-me-H3K9) were purchased from Millipore (Temecula, CA). Annexin V-FITC apoptosis detection kit II was obtained from BD Pharmingen (San Diego, CA, USA) and TRAPeze telomerase detection kit was purchased from Millipore (Millipore, Temecula, CA).
About PubCompare
Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.
We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.
However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.
Ready to get started?
Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required
Revolutionizing how scientists
search and build protocols!